Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.33 |
| ▸ | BACE1 | P56817 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.31 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.31 |
| ▸ | DRD2 | P14416 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16955298 | 0.88 | SLC6A2 (0.37) | SLC6A2SLC6A4SLC6A3CHRM2CHRM4 | |
| SCHEMBL16957299 | 0.76 | SLC6A2 (0.42) | SLC6A2SLC6A4SLC6A3CHRM2CHRM4 | |
| SCHEMBL16956564 | 0.75 | SLC6A2 (0.40) | SLC6A2SLC6A4SLC6A3NUDT1BACE1 | |
| SCHEMBL16957841 | 0.74 | PTGDR2 (0.40) | SLC6A2SLC6A4SLC6A3ALDH1A1MAPT | |
| SCHEMBL2499001 | 0.73 | S1PR1 (0.37) | SLC6A2CHRM1HTTCYP4F2CYP4A11 | |
| SCHEMBL16959595 | 0.72 | SLC6A2 (0.38) | SLC6A2SLC6A4SLC6A3CHRM2CHRM4 | |
| SCHEMBL16952573 | 0.72 | HTT (0.49) | SLC6A2SLC6A4SLC6A3HTTALDH1A1 | |
| SCHEMBL16962250 | 0.72 | SLC6A2 (0.49) | SLC6A2SLC6A4SLC6A3NUDT1BACE1 | |
| SCHEMBL16956427 | 0.72 | SLC6A4 (0.37) | SLC6A2SLC6A4SLC6A3CHRM2CHRM4 | |
| SCHEMBL16952736 | 0.72 | SLC6A2 (0.37) | SLC6A2SLC6A4SLC6A3CHRM2CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1813613-B1 | NOVEL FUSED IMIDAZOLE DERIVATIVE | MSD KK (JP) | 2012-12-19 | — | — | EP | disclosed |
| US-8030327-B2 | 3-[1-(2-chlorophenyl)ethoxy]-5-imidazo[1,2-a]pyridin-3-ylthiophene-2-carboxyamide; polo like kinase inhibitor; antitumor and anticarcinogenic agent; mitotic phase (M phase) of the cell cycle | MDS K.K. (JP) | 2011-10-04 | — | — | US | disclosed |
| CN-101098870-B | Novel fused imidazole derivative | BANYU PHARMA CO LTD | 2010-11-03 | — | — | CN | disclosed |
| US-20080103136-A1 | Novel Fused Imidazole Derivative | MSD K.K. (JP) | 2008-05-01 | — | — | US | disclosed |
| CN-101098870-A | Novel fused imidazole derivative | BANYU PHARMA CO LTD (JP) | 2008-01-02 | — | — | CN | disclosed |
| EP-1813613-A1 | NOVEL FUSED IMIDAZOLE DERIVATIVE | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2007-08-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080103136-A1 | Novel Fused Imidazole Derivative | HRH4, H1-4, H1-3 | SLC6A2 1153/4885SLC6A4 235/4885SLC6A3 337/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.